PetMed Express Inc

PetMed Express, trading as PETS, is a small-cap online pet pharmacy that sells prescription and over-the-counter medications, nutritional supplements and pet care products primarily in the US. The business operates an e-commerce platform and direct-to-consumer fulfilment, leveraging brand recognition built around the 1-800-PetMeds name. Investors should note the company’s modest market capitalisation (about $55.7m), which can mean lower liquidity and higher share price volatility compared with larger peers. Revenue drivers include repeat prescriptions and private-label products, while margins depend on sourcing, shipping costs and competitive pricing. Key risks include regulatory oversight of veterinary medicines, competition from larger retail and online players, and concentration of sales channels. For those considering PETS, view it as speculative and research operational performance, cash flow and regulatory developments carefully. This information is general and educational only, not personalised investment advice; values can fall as well as rise, so assess suitability for your circumstances.